Victoza (Liraglutide)

$160.00

Victoza (liraglutide) is a daily GLP-1 receptor agonist injection delivering steady appetite suppression and cardiovascular protection.

Available: 6mg/mL (2 Pens), 6mg/mL (3 Pens)

In Stock (70 available)

Choose Strength/Option:

Qty:

Why Choose Victoza?

Proven long-term safety profile with flexible daily dosing to tailor hunger management on a day-to-day basis.

Administer once daily subcutaneously at any time of day, independent of meals. Start at 0.6 mg daily for 1 week then titrate.

Drink plenty of fluids to avoid dehydration. Monitor kidney function in patients with renal risk.

Nausea, diarrhea, headache, and decreased appetite, which usually diminish over time.

Generic Name	Liraglutide
Brand Name	Victoza
Type of Medication	GLP-1 Receptor Agonist (Daily)
FDA Approval Date	January 25, 2010
Indications	To improve glycemic control and reduce major adverse cardiovascular events in adults with type 2 diabetes and metabolic overweight.
Dosage Forms	Multi-dose prefilled pen (6 mg/mL, delivers 0.6 mg, 1.2 mg, 1.8 mg)
Administration	Once daily subcutaneous injection at any time of day
Special Precautions	Risk of thyroid C-cell tumors. Ensure sufficient hydration to avoid renal complications.
Drug Interactions	Delays gastric emptying; caution with oral drugs requiring rapid absorption.
Use in Specific Populations	Contraindicated in pregnancy.
Prescription	Prescription Required
Manufacturer	Novo Nordisk

Choose your multi-pack option and benefit from express cold-chain delivery to your door.